Home
Novocol Pharma

Novocol Pharma Market Share Analysis for June 2026

Leading sterile injectable manufacturer providing turnkey CDMO fill-finish services including pharmaceutical development and device assembly.

Industry: N/A

Domainnovocolpharma.com

Year Founded--

Employees201 - 500

Annual Revenue$10M - $15M

Novocol Pharma

Novocol Pharma (including company regionals)

novocolpharma.com

See more website traffic and engagement information

Novocol Pharma Revenue up to June 2026 is 10M - 15M

revenue generated by Novocol Pharma top domains

Novocol Pharma top domains revenue over 3 years

Revenue for Novocol Pharma top domains

novocolpharma.com10M - 15M

See more with Sales Intelligence

Total visits to Novocol Pharma's top domains

Understand Novocol Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

novocolpharma.com827

See more with Sales Intelligence

Avg. visit duration in Novocol Pharma's top domains

Analyze Novocol Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

novocolpharma.com--

See more with Sales Intelligence

Avg. pageviews on Novocol Pharma's top domains

See how Novocol Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

novocolpharma.com1.04

See more with Sales Intelligence

Novocol Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Novocol Pharma

These are the website technologies, by industry, used by Novocol Pharma top domains

Payment & Currencies (8)

Cart Functionality

Content Management System (3)

WordPress

eCommerce (3)

WooCommerce

Widget (3)

reCAPTCHA

More Technologies

6

See all

News & Signals from Novocol Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsModerna Designs partnered with Novocol Healthcare Inc. on May 5th '23.Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a long-term agreement with Ontario-based Novocol Pharma, a leading sterile injectable contract development and manufacturing organization (CDMO), to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines expected to be produced in Canada.

NewsModerna Therapeutics Inc. partners with Novocol Healthcare Inc..Moderna is partnering with Novocol Pharma to add new manufacturing capabilities in their Cambridge facility that will complete the final steps of preparing and packaging respiratory mRNA vaccines.